ArticleBiosensors2022
Long Period Grating Mach-Zehnder Interferometer Based Immunosensor with Temperature and Bulk Refractive Index Compensation.
Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A long period grating Mach-Zehnder interferometer (LPGMZI) that consists of two identical long period gratings (LPGs) in a single fibre was developed to measure immunoglobulin M (IgM). The measured spectrum has fringes due to the interference between the core mode and cladding mode. This immunosensor inherits the advantages of an LPG and has the potential to compensate for unwanted signal changes due to bulk refractive index (RI) and temperature fluctuations by analysing interference fringes and their envelope. The external RI was measured from 1.3384 to 1.3670 in two different cases: (i) only the connecting section between the two LPGs is immersed or (ii) the whole LPGMZI is immersed. The fringes shift with an external RI in both scenarios, whereas the envelope stays still in case (i) or shifts at the same rate as the fringes in case (ii). The LPGMZI was also characterised at different temperatures between 25 °C and 30 °C by placing the whole LPGMZI in a water bath. The fringes and envelope shift at the same rate with temperature. The LPGMZI platform was then used to create an IgM immunosensor. The connecting section between the two LPGs was functionalised with anti-IgM and immersed into solutions with IgM concentrations from 20 μg/mL to 320 μg/mL. The fringes shift with IgM concentration and the envelope remains static. The results from this work show that LPGMZI has the potential to compensate for the temperature and bulk RI fluctuations and perform as a portable biosensor platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.